evenfolio

Healthcare · NSE: NH

Narayana Hrudayalaya

Price as of 12 Nov 2026
1,840.10−1.41%

Q2 FY27 earnings call · Guided by management

Call held 2 Nov 2026 · Read the filing on NSEFiling

4–5​%ROCE dilution from U.K. · U.K. · next 5 years or soJayaraman · p. 7
4–4.1​daysAverage length of stay (ALOS) · India · next 4 to 6 quartersRupert · p. 15
60–65​%Occupancy · India hospitalsJayaraman · p. 8
15​%Oncology share of India hospital revenue · India hospitalsJayaraman · Q&A · p. 4
M.Cap
₹37,604Cr
P/E
43.5×
1Y return
+4.60%
From 52W high
−12.1%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue2,8441,644+73.0%2,684+6.0%
EBITDA554403+37.6%470+17.9%
EBITDA margin19.5%24.5%-501 bps17.5%+198 bps
One-off items-2————
PBTProfit before tax343297+15.7%262+30.9%
Net profit301258+16.5%207+45.3%
EPS (₹)14.8212.72+16.5%10.20+45.3%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

More figures from the call

India hospitals · Demand
6–7​%International patients share of hospital revenue
“International patients contribute around 6% to 7% of hospital revenue, but it is not something we specifically target.”
R. Venkatesh · Group Chief Operating Officerp. 8
U.K. · Other
4–5​monthsTime to digital platform certifications · about 4 to 5 months
“We think that's about 4 to 5 months away from getting all certifications, and then we'll start the implementation of Athma, which will be a significant change forward.”
Anesh Shetty · Managing Director of International Businessesp. 14
U.K. · Margins and costs
3–4​million (currency not stated)Additional quarterly revenue needed to see cost benefits
“So even if you go 1 or 2 quarters back, which is just 3 million, 4 million additional revenue for the quarter, we will start seeing these benefits flow in.”
Anesh Shetty · Managing Director of International Businessesp. 18

In short

  1. 01India business margin rose to more than 26%; management does not target or guide on margins.
  2. 02Combined loss of India insurance and clinics fell to about Rs 22 crore from Rs 33 crore last quarter.
  3. 03Cayman insurance losses fell to $1.1 million from $3.7 million; big repricing reset due July 2027.
  4. 04U.K. revenue dipped due to slower NHS contracting; cost synergies on plan but not yet visible in earnings.
  5. 05Group ROCE is 15% to 16%; U.K. dilution of 4% to 5% to be bridged over about 5 years.
  6. 06Management expects stronger inpatient and outpatient footfall growth in Q3 and Q4.
  7. 07ALOS targeted at 4 to 4.1 days over the next 4 to 6 quarters.
  8. 08H1 cash conversion was lower due to slower collections in India and Cayman; expected to normalise.

Capex

India: Full ROCE effect expected once India comes off the capex cycle

Sandhya Jayaraman · Group Chief Financial Officer · p. 7
“As India also comes off the capex cycle, I think that's when the full effect of the -- all the measures will show on the ROCE.”

Capacity

India: No bed addition as of now

Viren Shetty · Vice Chairman · p. 8
“As of now, no bed addition.”

India hospitals: No capacity added and occupancy flat for several quarters

Sandhya Jayaraman · Group Chief Financial Officer · p. 9
“One good way to look at our numbers is that we haven't added any capacity and our occupancy has also not increased in the past several quarters.”

India: Adding more beds and facilities in India hospitals

Viren Shetty · Vice Chairman · p. 10
“We are adding more beds. We are adding more facilities in the hospitals over here. But our ambition is a lot more than that.”

Bed addition guidance to be shared 1 quarter before commissioning

Sandhya Jayaraman · Group Chief Financial Officer · p. 20
“As and when our facilities are ready to be commissioned, we will share that guidance 1 quarter in advance.”

Segments

India health insurance: India insurance claims ratios have come down quarter-to-quarter

Ravi Vishwanath · Board Member · Q&A · p. 5
“The claims ratios themselves, if you look at quarter-to-quarter, that has come down significantly and it is trending -- continues to trend in the right direction.”

India health insurance: Insurance strategy being adapted; spending kept as low as possible

Viren Shetty · Vice Chairman · Q&A · p. 5
“There were a set of strategies we had in mind when we first started out, and some did not work as well as expected. We are adapting and pivoting, and we're keeping the amount of money spent as low as possibly we can.”

Clinics: Committed spending on clinics will continue

Viren Shetty · Vice Chairman · Q&A · p. 5
“There was an amount of money we had committed towards spending on the clinics, which have proven themselves to be an extremely valuable resource for all our patients and for doctors to run their evening OPDs. That will continue because its value to the larger network is proven.”

India health insurance: Insurance aims to break even at a much smaller book than peers

Viren Shetty · Vice Chairman · Q&A · p. 6
“We will spend in moderate amounts to keep our customers very happy to make sure that the claims don't go above and beyond what we had estimated for and to cut the cost in insurance distribution, which is currently a very high priority for the IRDAI Chairman, so that we can break even at a much smaller book than the peer set.”

Cayman insurance: Cayman insurance losses down from $3.7 million to $1.1 million

Nishant Singh · Vice President · p. 6
“Even for Cayman, if you look at the insurance losses, the number is down from $3.7 million to $1.1 million.”

Demand

India: India IP volumes up 4% year-on-year; OP footfall up about 12.5%

R. Venkatesh · Group Chief Operating Officer · p. 3
“So on IP volumes, we've seen 4% increase year-on-year. OP footfall, we've seen around 12.5% growth.”

Eastern region: Much stronger footfall growth expected from Eastern region in Q3

R. Venkatesh · Group Chief Operating Officer · p. 7
“We expect much stronger footfall growth from the Eastern region in Q3.”

India: Good inpatient and outpatient footfall growth foreseen in Q3 and Q4

R. Venkatesh · Group Chief Operating Officer · p. 8
“And with the strong base and good funnel which have been created over the last 2 quarters across all the regions, we foresee good footfall growth both from inpatient side and outpatient side in Q3 and Q4.”

India hospitals: International patient growth is organic, mainly from Bangladesh

R. Venkatesh · Group Chief Operating Officer · p. 8
“The growth is purely organic and comes mainly from Bangladesh, because of the brand and loyalty we have built there over the last 2.5 decades, supported by easier visa and travel conditions.”

Cayman: Cayman sees continued growth from international patients

Anesh Shetty · Managing Director of International Businesses · p. 16
“We continue to see good growth from non-Cayman sources, that is international patients.”

Margins and costs

India: India business margin rose to more than 26%

R. Venkatesh · Group Chief Operating Officer · p. 3
“And on the margin side, yes, it has gone up to more than 26%, which is now among the best in the industry, even though our ARPOB remains well below peers.”

India: Doctors and nursing costs fell 1.9% QoQ on operating leverage

R. Venkatesh · Group Chief Operating Officer · p. 3
“Along with better realizations, we've also had the benefit of operating leverage on the costs where our doctors and nursing costs have come down by 1.9% QoQ, which has added to the margin.”

India: Focus is on sustaining margins at current levels

R. Venkatesh · Group Chief Operating Officer · p. 3
“And our focus will remain on seeing how we can sustain these margins at current levels.”

Margin expansion is not a target; volume growth is the goal

Viren Shetty · Vice Chairman · p. 4
“So margin expansion isn't the thing that we target. What we're looking for is accessing the largest pool of patients in all the cities that we operate in. Volume growth is what we want to pursue.”

International: Bangalore GCC serves all international operations with synergies

Viren Shetty · Vice Chairman · p. 10
“So there are definite synergies that we've seen with running a very large GCC for all our international operations out of our corporate office in Bangalore.”

Debt and working capital

Lower H1 cash conversion due to slower collections in India and Cayman

Sandhya Jayaraman · Group Chief Financial Officer · p. 17
“The reason you have seen a slightly lesser cash conversion in H1 is coming from India and Cayman. There has been a slight delay in both India and Cayman in terms of collections.”

U.K.: U.K. cash conversion not a problem; NHS pays on time and partly in advance

Sandhya Jayaraman · Group Chief Financial Officer · p. 17
“So the cash conversion for U.K. is not a problem. In fact, NHS is a very good payer; it pays on time and partially in advance.”

Collections expected to normalise on a full-year basis

Sandhya Jayaraman · Group Chief Financial Officer · p. 17
“Typically, on a full-year basis, this normalizes: in some quarters collections are a little slow, but we catch up over the next few months. So that's what we are expecting.”

Management

India: About 900 postgraduates in training across the network

Emmanuel Rupert · p. 19
“We have close to around 900 postgraduates in training across the entire network.”

India: Little attrition at senior doctor level

Emmanuel Rupert · p. 19
“We don't see too much of attrition at the senior level.”

India: More than 3,000 nursing students in training

Emmanuel Rupert · p. 19
“We have more than 3,000 nursing students in training.”

One-offs

Cayman insurance: Cayman $1.1 million loss includes a one-off from summer holiday months

Anesh Shetty · Managing Director of International Businesses · p. 14
“But this -- the $1.1 million does have some one-off because it includes the summer school holiday months, when people tend to defer elective care, they'll be on holidays, travel with family, etcetera.”

Risks

India hospitals: Some ups and downs possible as oncology price cap is implemented

Sandhya Jayaraman · Group Chief Financial Officer · Q&A · p. 4
“There may be some ups and downs as this is implemented, which we will work through as we understand it better.”

Eastern cluster: Transition issue with Bengal government scheme patients expected to settle next quarter

R. Venkatesh · Group Chief Operating Officer · p. 7
“In the Eastern cluster, there was a transition issue in porting certain categories of government scheme patients in Bengal, which should settle in the coming quarter, after which IP footfalls will gradually pick up.”

U.K.: U.K. NHS commissioning and patient acquisition partly outside company control

Anesh Shetty · Managing Director of International Businesses · p. 11
“There are certain aspects which given it's a new market, a, we are still learning about the nuances and b, a little out of our control with regards to NHS revenue commissioning and external patient acquisition.”

Cybersecurity a major concern; recent software vulnerability patched

Viren Shetty · Vice Chairman · p. 11
“For example, there was a recent software vulnerability that we were able to patch very quickly. But in the end, this is never ending, and it is something you just have to spend a lot of time and effort towards.”

More spending on IT security systems needed

Viren Shetty · Vice Chairman · p. 11
“We just need to spend more money and build better systems and obviously hope and pray that bad things don't happen that are well beyond our control.”

Other

India: ARPOB rose from INR17.5 million to INR19.5 million annualised, year-on-year

R. Venkatesh · Group Chief Operating Officer · p. 3
“ARPOB, as you said, has increased from INR17.5 million to INR19.5 million (annualised) year-on-year, as we focus more on high-end procedures and greater use of robotics.”

India health insurance and clinics: Combined insurance and clinics loss fell to INR22 crores from INR33 crores last quarter

Nishant Singh · Vice President · p. 6
“The combined loss of the 2 businesses was around INR33 crores last quarter, and this quarter it is INR22 crores. So the losses have come down actually.”

AI use is limited to practical applications such as radiology and voice bots

Viren Shetty · Vice Chairman · p. 6
“For us, our AI use cases are much more measured and more grounded in practical application. AI in radiology predates LLMs.”

Group ROCE is between 15% and 16%

Sandhya Jayaraman · Group Chief Financial Officer · p. 7
“So at a group level, our ROCE is between 15% to 16%. That's because we've come off a huge investment in Cayman as well as the investment we've made in U.K. and India entering the capex phase.”

Clinics: Clinic business being merged into hospital business for reporting

Sandhya Jayaraman · Group Chief Financial Officer · p. 9
“We are merging the clinic business into the hospital business, so going forward it will be useful to only look at the insurance number.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools